Metraipolis › archive › dc_217eaf465017
Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics — Europe PMC PMID:41328335
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41328335
- DOI
- 10.7150/thno.117363
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T05:14:26.008Z
- SHA-256 of the archived text
23766735cd66a41027a43b79b805e8216ad55bff880f0ee8ac1e391817fbed31- Stable URL of this page
https://metraipolis.com/documento/dc_217eaf465017
How to cite
Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics — Europe PMC PMID:41328335 — Europe PMC (en), https://europepmc.org/article/MED/41328335 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_217eaf465017 (Metraipolis archive dc_217eaf465017, sha256 23766735cd66a41027a43b79b805e8216ad55bff880f0ee8ac1e391817fbed31)
BibTeX
@misc{dc217eaf465017,
title = {Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics — Europe PMC PMID:41328335},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41328335},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_217eaf465017; sha256 23766735cd66a41027a43b79b805e8216ad55bff880f0ee8ac1e391817fbed31},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41328335. Agents can read the archived copy with the MCP tool read_document.